search
Blood Work
Trends
- 1University of Arizona scientists develop drug candidate for vascular dementia●Vascular dementia has no approved treatments. U of A scientists hope to change that with an inflammation-fighting drug candidate.
University of Arizona scientists are working on an inflammation-fighting drug candidate aimed at vascular dementia, a condition that currently has no approved treatments. The research, announced by the university, targets the inflammation believed to drive blood vessel-related cognitive decline. If successful, the candidate could become the first approved therapy for a disease affecting millions of older adults worldwide.